Metraipolis › archive › dc_b2d2beddccb6

Acute Myeloid Leukemia(AML) proteins for in silico drug design using pharmacophore modeling, molecular docking and molecular dynamics simulation — Europe PMC PMID:42685040

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42685040
DOI
10.1371/journal.pone.0354456
License (as archived)
solo-consultazione
Archived
2026-10-16T05:20:49.940Z
SHA-256 of the archived text
84b11b56da7dbdbe8eeb68db7a40e54087fbe98e50634d68aeffbbd0aa5bcfcb
Stable URL of this page
https://metraipolis.com/documento/dc_b2d2beddccb6

How to cite

Acute Myeloid Leukemia(AML) proteins for in silico drug design using pharmacophore modeling, molecular docking and molecular dynamics simulation — Europe PMC PMID:42685040 — Europe PMC (en), https://europepmc.org/article/MED/42685040 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b2d2beddccb6 (Metraipolis archive dc_b2d2beddccb6, sha256 84b11b56da7dbdbe8eeb68db7a40e54087fbe98e50634d68aeffbbd0aa5bcfcb)
BibTeX
@misc{dcb2d2beddccb6,
  title = {Acute Myeloid Leukemia(AML) proteins for in silico drug design using pharmacophore modeling, molecular docking and molecular dynamics simulation — Europe PMC PMID:42685040},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42685040},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b2d2beddccb6; sha256 84b11b56da7dbdbe8eeb68db7a40e54087fbe98e50634d68aeffbbd0aa5bcfcb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42685040. Agents can read the archived copy with the MCP tool read_document.